Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

CERUBIDINE

DAUNORUBICIN HYDROCHLORIDE

Standard Dose
EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview CERUBIDINE is listed in Drugs@FDA under application 050484 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient DAUNORUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor WYETH AYERST Submission history Latest submission status date: 1994-09-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview CERUBIDINE is listed in Drugs@FDA under application 050484 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient DAUNORUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor WYETH AYERST Submission history Latest submission status date: 1994-09-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.
CERUBIDINE (DAUNORUBICIN HYDROCHLORIDE) | Drug Monograph | MedicHelpline